GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM39437
Query DataSets for GSM39437
Status
Public on Apr 01, 2005
Title
pp66-4
Sample type
RNA
Source name
Staged C. elegans embryos
Organism
Caenorhabditis elegans
Extracted molecule
total RNA
Description
Mutant genotype pie-1(zu154); pal-1(RNAi) 66 minutes after the 4-cell embryonic stage at 22 degrees C
Sample_genotype: pp
Sample_time: 66
Submission date
Jan 24, 2005
Last update date
May 27, 2005
Contact name
Andrew Hill
E-mail(s)
andrew.hill@pfizer.com
Phone
617-674-6341
Organization name
Pfizer
Department
Research Business Technology
Street address
300 Technology Square
City
Cambridge
State/province
MA
ZIP/Postal code
02139
Country
USA
Platform ID
GPL200
Series (1)
GSE2180
C. elegans embryonic timecourse in wt and mutant embryos
Data table header descriptions
ID_REF
Affymetrix Qualifier
VALUE
RMA calulated using Bioconductor Affy package (http://www.bioconductor.org)
Data table
ID_REF
VALUE
171720_x_at
4.06690747966212
171721_x_at
5.64978618617813
171722_x_at
5.78162513428996
171723_x_at
4.04666588647047
171724_x_at
4.51210780176514
171725_x_at
4.71202709306102
171726_x_at
4.30358120174453
171727_x_at
3.02469014110731
171728_x_at
3.16283145084148
171729_x_at
6.69409094012757
171730_x_at
2.73742447431677
171731_x_at
8.2579945196353
171732_x_at
6.34788321895156
171733_x_at
3.8162100898014
171734_x_at
10.2783638070519
171735_x_at
3.58254486010411
171736_x_at
8.77640816879788
171737_x_at
6.64193800629724
171738_x_at
5.58811684208538
171739_x_at
3.16669031687239
Total number of rows:
22625
Table truncated, full table size
608 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM39437.CEL.gz
2.7 Mb
(ftp)
(http)
CEL
GSM39437.EXP.gz
326 b
(ftp)
(http)
EXP
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|
